Brief: Aptorum Group Plans To Submit An IND Submission With FDA For SACT-1 IN H2 2020

Aptorum

10/02/2020 13:15

Feb 10 (Reuters) - Aptorum Group Ltd  APM.O :
    * APTORUM GROUP LTD - ANNOUNCES POSITIVE DATA & DEVELOPMENT
IN
RELATION TO ITS REPURPOSED DRUG CANDIDATE, SACT-1, FOR THE
TREATMENT OF NEUROBLASTOMA
    * APTORUM GROUP LTD - PLANS TO SUBMIT AN IND SUBMISSION WITH
FDA
FOR SACT-1 IN H2 2020

Source: (https://bit.ly/3bqOfwE)
Further company coverage:  APM.O 

 ((Reuters.Briefs@thomsonreuters.com;))